 |
| CLICK HERE TO VIEW CURRENT ISSUE |
|
 |
|
FOOD & DRUG ADMINISTRATION ISSUES NEW GUIDANCE ON BIOTECH DERIVED CROPS
Feb. 23, 2024
Agri-Pulse reports:
FDA has developed new recommendations for biotech companies and plant breeders who want to bring new gene-edited crop traits to market. FDA's 22-page guidance lays out two processes, one more streamlined than the other.
To view the report click here
For crops that pose no food safety questions, FDA says a voluntary premarket meeting with the agency is enough. For other crops, FDA recommends a premarket consultation process in line with what has long been standard practice for new biotech traits.
"Participation in these programs is not required by law, but these programs can help developers ensure that they are meeting their legal obligation to market only safe and lawful food," FDA says in the guidance. "Such consultations or meetings also would provide FDA with an awareness of the genome-edited plant products potentially on the market."
|
|
|
|
|
